{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:43:32Z","timestamp":1768290212722,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016221","name":"Rowan University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016221","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gallbladder cancer (GBC) is associated with a high mortality rate. Asian American (AsA) are among the fastest-growing populations in the United States, yet little is known about the disparity of GBC within this cohort. This study identified\u00a0trends in treatment and outcomes for GBC in a disaggregated fashion, specifically for this population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective analysis of the National Cancer Database (NCDB) between 2010 and 2019 examining all patients treated for gallbladder cancer was performed. Basic demographic factors were identified for patients of Caucasian, African American, and disaggregated Asian subpopulations. Survival curves were used to identify differences in median overall survival, and a multivariate analysis was performed to determine which factors impact overall survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1317 (5%) patients were of AsA origin. Median survival for the overall AsA population is 15.1 months compared with Caucasian (11.5 months) and African Americans (11.4 months) (<jats:italic>p<\/jats:italic> &lt; 0.0001). Within the AsA groups, the Korean subpopulation had the lowest survival at 12.6 months, whereas Filipinos had the longest survival at 19.1 months (<jats:italic>p<\/jats:italic> &lt; 0.0001). Patients of Filipino descent had the highest rate of surgical resection but lower chemotherapy utilization. Conversely, Korean patients had the highest utilization of multimodality therapy. Multivariate analysis demonstrated that belonging to Chinese, Filipino, or Indian ethnicity was associated with decreased risk of mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There are disparate differences in survival for patients with GBC between AsA groups. Socioeconomic, genetic, and epigenetic factors may influence these differences. Further research is needed to delineate the causes of this disparity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-024-16168-x","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T14:04:46Z","timestamp":1726063486000},"page":"8699-8711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unmasking Disparities in Gallbladder Cancer Outcomes in the Disaggregated Asian American Population"],"prefix":"10.1245","volume":"31","author":[{"given":"Keshav","family":"Kooragayala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis J.","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanay Veer","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Dibato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"16168_CR1","unstructured":"CDC. Leading causes of death: males\u2014all races and origins\u2014United States; 2018."},{"issue":"3","key":"16168_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3322\/caac.21335","volume":"66","author":"LA Torre","year":"2016","unstructured":"Torre LA, Sauer AMG, Chen MSJ, Kagawa-Singer M, Jemal A, Siegel RL. Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: converging incidence in males and females. CA Cancer J Clin. 2016;66(3):182\u2013202. https:\/\/doi.org\/10.3322\/caac.21335.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"16168_CR3","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1158\/1055-9965.EPI-15-0199","volume":"24","author":"SJ Henley","year":"2015","unstructured":"Henley SJ, Weir HK, Jim MA, Watson M, Richardson LC. Gallbladder cancer incidence and mortality, United States 1999\u20132011. Cancer Epidemiol Biomark Prev. 2015;24(9):1319\u201326. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0199.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"16168_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"16168_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"16168_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3322\/canjclin.54.2.78","volume":"54","author":"E Ward","year":"2004","unstructured":"Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race\/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78\u201393. https:\/\/doi.org\/10.3322\/canjclin.54.2.78.","journal-title":"CA Cancer J Clin."},{"key":"16168_CR7","unstructured":"Budiman A, Ruiz NG. Key facts about Asian Americans, a diverse and growing population. Published online 2021."},{"key":"16168_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/S40615-024-02067-0","author":"DT Zhu","year":"2024","unstructured":"Zhu DT, Lai A, Park A, Zhong A, Tamang S. Disparities in cancer mortality among disaggregated Asian American subpopulations, 2018\u20132021. J Racial Ethn Health Dispar. 2024. https:\/\/doi.org\/10.1007\/S40615-024-02067-0.","journal-title":"J Racial Ethn Health Dispar"},{"issue":"4","key":"16168_CR9","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1245\/s10434-023-13103-4","volume":"30","author":"CM Eden","year":"2023","unstructured":"Eden CM, Johnson J, Syrnioti G, Malik M, Ju T. The Landmark Series: the breast cancer burden of the Asian American population and the need for disaggregated data. Ann Surg Oncol. 2023;30(4):2121\u20137. https:\/\/doi.org\/10.1245\/s10434-023-13103-4.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"16168_CR10","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1245\/s10434-023-14454-8","volume":"31","author":"K Kooragayala","year":"2024","unstructured":"Kooragayala K, Lou J, Dibato J, Hong YK. Disparities in pancreatic cancer outcomes in the disaggregated Asian American population. Ann Surg Oncol. 2024;31(2):1298\u2013309. https:\/\/doi.org\/10.1245\/s10434-023-14454-8.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"16168_CR11","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1245\/s10434-023-13339-0","volume":"30","author":"B Jain","year":"2023","unstructured":"Jain B, Bajaj SS, Patel TA, et al. Colon cancer disparities in stage at presentation and time to surgery for Asian Americans, Native Hawaiians, and Pacific Islanders: a study with disaggregated ethnic groups. Ann Surg Oncol. 2023;30(9):5495\u2013505. https:\/\/doi.org\/10.1245\/s10434-023-13339-0.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"16168_CR12","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1200\/OP.21.00412","volume":"18","author":"B Jain","year":"2022","unstructured":"Jain B, Ng K, Santos PMG, et al. Prostate cancer disparities in risk group at presentation and access to treatment for Asian Americans, Native Hawaiians, and Pacific Islanders: a study with disaggregated ethnic groups. JCO Oncol Pract. 2022;18(1):e204\u201318. https:\/\/doi.org\/10.1200\/OP.21.00412.","journal-title":"JCO Oncol Pract"},{"key":"16168_CR13","unstructured":"SEER. Gallbladder SEER 5-year relative survival rates, 2014\u20132020 by race\/ethnicity, both sexes, all ages, all stages. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/application.html?site=38&data_type=4&graph_type=5&compareBy=race&chk_race_1=1&chk_race_4=4&series=9&sex=1&age_range=1&stage=101&advopt_precision=1&advopt_show_ci=on&hdn_view=0"},{"issue":"2","key":"16168_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/ceh.2019.85166","volume":"5","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5(2):93\u2013102. https:\/\/doi.org\/10.5114\/ceh.2019.85166.","journal-title":"Clin Exp Hepatol"},{"key":"16168_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020234","author":"P P\u00e9rez-Moreno","year":"2022","unstructured":"P\u00e9rez-Moreno P, Riquelme I, Garc\u00eda P, Brebi P, Roa JC. Environmental and lifestyle risk factors in the carcinogenesis of gallbladder cancer. J Pers Med. 2022. https:\/\/doi.org\/10.3390\/jpm12020234.","journal-title":"J Pers Med."},{"issue":"19","key":"16168_CR16","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1001\/jama.283.19.2579","volume":"283","author":"K Fiscella","year":"2000","unstructured":"Fiscella K, Franks P, Gold MR, Clancy CM. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000;283(19):2579\u201384. https:\/\/doi.org\/10.1001\/jama.283.19.2579.","journal-title":"JAMA"},{"issue":"12","key":"16168_CR17","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1007\/s11605-017-3537-4","volume":"21","author":"SC O\u2019Connor","year":"2017","unstructured":"O\u2019Connor SC, Mogal H, Russell G, et al. The effects of travel burden on outcomes after resection of extrahepatic biliary malignancies: results from the US Extrahepatic Biliary Consortium. J Gastrointest Surg. 2017;21(12):2016\u201324. https:\/\/doi.org\/10.1007\/s11605-017-3537-4.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"16168_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3748\/wjg.v17.i2.174","volume":"17","author":"SE Lee","year":"2011","unstructured":"Lee SE, Jang JY, Lim CS, Kang MJ, Kim SW. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol. 2011;17(2):174\u201380. https:\/\/doi.org\/10.3748\/wjg.v17.i2.174.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"16168_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/hpb.12444","volume":"17","author":"TA Aloia","year":"2015","unstructured":"Aloia TA, J\u00e1rufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17(8):681\u201390. https:\/\/doi.org\/10.1111\/hpb.12444.","journal-title":"HPB (Oxford)"},{"issue":"22","key":"16168_CR20","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1056\/NEJMsa1010705","volume":"364","author":"JF Finks","year":"2011","unstructured":"Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011;364(22):2128\u201337. https:\/\/doi.org\/10.1056\/NEJMsa1010705.","journal-title":"N Engl J Med"},{"issue":"16","key":"16168_CR21","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","volume":"30","author":"AM Horgan","year":"2012","unstructured":"Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30(16):1934\u201340. https:\/\/doi.org\/10.1200\/JCO.2011.40.5381.","journal-title":"J Clin Oncol"},{"key":"16168_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","volume":"15","author":"N Ma","year":"2015","unstructured":"Ma N, Cheng H, Qin B, Zhong R, Wang B. Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis. BMC Cancer. 2015;15:615. https:\/\/doi.org\/10.1186\/s12885-015-1617-y.","journal-title":"BMC Cancer"},{"issue":"5","key":"16168_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(18)30915-X.","journal-title":"Lancet Oncol"},{"issue":"7","key":"16168_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.6004\/jnccn.2023.0035","volume":"21","author":"AB Benson","year":"2023","unstructured":"Benson AB, D\u2019Angelica MI, Abrams T, et al. NCCN Guidelines\u00ae Insights: biliary tract cancers, version 2.2023. J Natl Compr Canc Netw. 2023;21(7):694\u2013704. https:\/\/doi.org\/10.6004\/jnccn.2023.0035.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"16168_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12\u201327. https:\/\/doi.org\/10.1016\/j.cell.2012.06.013.","journal-title":"Cell."},{"issue":"11","key":"16168_CR26","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11):1148\u201359. https:\/\/doi.org\/10.1056\/NEJMra072067.","journal-title":"N Engl J Med"},{"issue":"6632","key":"16168_CR27","doi-asserted-by":"publisher","first-page":"eaaw3835","DOI":"10.1126\/science.aaw3835","volume":"379","author":"AP Feinberg","year":"2023","unstructured":"Feinberg AP, Levchenko A. Epigenetics as a mediator of plasticity in cancer. Science. 2023;379(6632):eaaw3835. https:\/\/doi.org\/10.1126\/science.aaw3835.","journal-title":"Science"},{"issue":"Pt 3","key":"16168_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","volume":"86","author":"GP Nagaraju","year":"2022","unstructured":"Nagaraju GP, Dariya B, Kasa P, Peela S, El-Rayes BF. Epigenetics in hepatocellular carcinoma. Semin Cancer Biol. 2022;86(Pt 3):622\u201332. https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.017.","journal-title":"Semin Cancer Biol"},{"key":"16168_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ebiom.2019.08.064","volume":"47","author":"G Li","year":"2019","unstructured":"Li G, Xu W, Zhang L, et al. Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma. EBioMedicine. 2019;47:128\u201341. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.064.","journal-title":"EBioMedicine"},{"issue":"6","key":"16168_CR30","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.18632\/aging.102923","volume":"12","author":"X Huang","year":"2020","unstructured":"Huang X, Yang C, Wang J, Sun T, Xiong H. Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications. Aging. 2020;12(6):4970\u201395. https:\/\/doi.org\/10.18632\/aging.102923.","journal-title":"Aging"},{"issue":"1","key":"16168_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbcan.2017.01.001","volume":"1868","author":"A Ahmad","year":"2017","unstructured":"Ahmad A, Azim S, Zubair H, et al. Epigenetic basis of cancer health disparities: looking beyond genetic differences. Biochim Biophys Acta Rev Cancer. 2017;1868(1):16\u201328. https:\/\/doi.org\/10.1016\/j.bbcan.2017.01.001.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"16168_CR32","doi-asserted-by":"publisher","first-page":"e37928","DOI":"10.1371\/journal.pone.0037928","volume":"7","author":"S Wang","year":"2012","unstructured":"Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, Kwabi-Addo B. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS One. 2012;7(5):e37928. https:\/\/doi.org\/10.1371\/journal.pone.0037928.","journal-title":"PLoS One"},{"issue":"11","key":"16168_CR33","first-page":"4556","volume":"61","author":"KO Toyooka","year":"2001","unstructured":"Toyooka KO, Toyooka S, Virmani AK, et al. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res. 2001;61(11):4556\u201360.","journal-title":"Cancer Res"},{"key":"16168_CR34","doi-asserted-by":"publisher","first-page":"1079037","DOI":"10.3389\/fonc.2023.1079037","volume":"13","author":"C Stevens","year":"2023","unstructured":"Stevens C, Hightower A, Buxbaum SG, Falzarano SM, Rhie SK. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. Front Oncol. 2023;13:1079037. https:\/\/doi.org\/10.3389\/fonc.2023.1079037.","journal-title":"Front Oncol"},{"issue":"7801","key":"16168_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","volume":"580","author":"J Li","year":"2020","unstructured":"Li J, Xu C, Lee HJ, et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature. 2020;580(7801):93\u20139. https:\/\/doi.org\/10.1038\/s41586-020-2135-x.","journal-title":"Nature"},{"issue":"9","key":"16168_CR36","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1245\/s10434-015-4388-4","volume":"22","author":"J Wang","year":"2015","unstructured":"Wang J, Sun Y, Bertagnolli MM. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Ann Surg Oncol. 2015;22(9):2965\u201371. https:\/\/doi.org\/10.1245\/s10434-015-4388-4.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"16168_CR37","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/jso.25389","volume":"119","author":"RM Rhome","year":"2019","unstructured":"Rhome RM, Ru M, Moshier E, Mazumdar M, Buckstein MH. Stage-matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States. J Surg Oncol. 2019;119(6):737\u201348. https:\/\/doi.org\/10.1002\/jso.25389.","journal-title":"J Surg Oncol"},{"issue":"9","key":"16168_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1177\/000313480006600904","volume":"66","author":"CP Theuer","year":"2000","unstructured":"Theuer CP. Asian gastric cancer patients at a southern California comprehensive cancer center are diagnosed with less advanced disease and have superior stage-stratified survival. Am Surg. 2000;66(9):821\u20136.","journal-title":"Am Surg"},{"issue":"1","key":"16168_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11605-019-04403-w","volume":"24","author":"A Uppal","year":"2020","unstructured":"Uppal A, Dehal A, Chang SC, et al. The immune microenvironment impacts survival in western patients with gastric adenocarcinoma. J Gastrointest Surg. 2020;24(1):28\u201338. https:\/\/doi.org\/10.1007\/s11605-019-04403-w.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"16168_CR40","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10549-010-1173-8","volume":"127","author":"ML Telli","year":"2011","unstructured":"Telli ML, Chang ET, Kurian AW, et al. Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat. 2011;127(2):471\u20138. https:\/\/doi.org\/10.1007\/s10549-010-1173-8.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16168-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16168-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16168-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T13:06:05Z","timestamp":1731071165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16168-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":40,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["16168"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16168-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"8 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no proprietary or commercial interest in any product or technology mentioned or discussed in this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}